Mode of action of hypoglycemic agents. 3. Studies on 5-methoxy indole-2-carboxylic acid and quinaldic acid.
D000818:Animals; D002210:Caprylates / Q000494:pharmacology; D002951:Citrates / Q000378:metabolism; D008058:Dihydrolipoamide Dehydrogenase / Q000037:antagonists & inhibitors; D004140:Dinitrophenols / Q000494:pharmacology; D005971:Glutamates / Q000378:metabolism; D006885:Hydroxybutyrates / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007656:Ketoglutaric Acids / Q000378:metabolism; D007668:Kidney / Q000166:cytology; D008660:Metabolism / Q000187:drug effects; D008928:Mitochondria / Q000378:metabolism; D008930:Mitochondria, Liver / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D011804:Quinolines / Q000494:pharmacology*; D051381:Rats; D013386:Succinates / Q000378:metabolism
D002210:Caprylates; D002951:Citrates; D004140:Dinitrophenols; D005971:Glutamates; D006885:Hydroxybutyrates; D007004:Hypoglycemic Agents; D007211:Indoles; D007656:Ketoglutaric Acids; D011773:Pyruvates; D011804:Quinolines; D013386:Succinates; D008058:Dihydrolipoamide Dehydrogenase